ADARx Pharmaceuticals, Inc. (ADRX) vs Ocular Therapeutix, Inc. (OCUL)

ADARx Pharmaceuticals, Inc. ADRX 13.20 −0.68%
Ocular Therapeutix, Inc. OCUL 6.62 +2.95%

ADARx Pharmaceuticals, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.5B and $1.4B).

Metric	ADRX	OCUL	Biotechnology median
P/E	—	n/m	10.60
P/S	—	28.61	9.40
P/B	—	2.86	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	18.51	9.02
Earnings yield	—	(21.45%)	(32.88%)
Free cash flow yield	—	(17.13%)	(23.13%)

Metric	ADRX	OCUL	Biotechnology median
Gross margin	—	87.11%	68.51%
Operating margin	—	(603.04%)	0.00%
Net margin	—	(579.10%)	0.00%
Free cash flow margin	—	(490.07%)	0.00%
Return on equity	—	(72.99%)	(51.96%)
Return on assets	—	(53.70%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	OCUL	Biotechnology median
Revenue growth (TTM)	—	(8.14%)	6.76%
EPS growth (last fiscal year)	—	(16.39%)	29.88%
Revenue growth, 5-year CAGR	—	24.45%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	OCUL	Biotechnology median
Debt to equity	—	0.14	0.00
Current ratio	—	13.11	4.97
Net debt to EBITDA	—	2.51	1.01

Metric	ADRX	OCUL	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADRX	OCUL	Biotechnology median
Market cap	1.47b	1.41b	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack